Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinomaKevin Bi, Eliezer M. Van Allen, Meng Xiao He et al.|Cancer Cell|2021Cited by 624
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K. Mehta, Jennifer L. Guerriero, Emily Cheney et al.|Nature Cancer|2020Cited by 271
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical OutcomesAndriy Marusyk, Kornélia Polyák, Doris P. Tabassum et al.|Cancer Research|2016Cited by 140
Programs, origins and immunomodulatory functions of myeloid cells in gliomaTyler E. Miller, B Bernstein, Chadi A. El Farran et al.|Nature|2025Cited by 107
DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate ImmunityJennifer L. Guerriero, Wei‐Xing Zong|The Journal of Immunology|2011Cited by 87